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Abstract
Background: Although circular collimator arcs (CCA) and dynamic conformal arcs (DCA) are commonly used linear
accelerator-based treatment planning techniques for intracranial stereotactic radiosurgery (SRS) of a small single
lesion, these two techniques have not been rigorously compared in terms of tumor shape. Therefore, this study
compared clinical CCA plans with re-planned DCA plans using conformity index (CI) and V12Gy (volume of normal
brain tissue receiving 12 Gy or higher) from a perspective of asymmetry (Asym) of planning target volume (PTV).
Methods: Ninety-five clinical CCA plans delivered for a small single lesion with PTV size < 1.4 cm3 were selected
and re-planned using DCA. PTV Asym (%) was defined and calculated from three dimensions of PTV. A pair of the
95 plans was first considered as one group without grouping and then categorized into two groups with
respective to either PTV size or PTV Asym, and four groups with respect to PTV size and PTV Asym. For grouping,
median values of PTV size and PTV Asym were used. A non-parametric paired test was performed for CI and V12Gy
to compare CCA and DCA plans in each group.
Results: Median values of PTV size and PTV Asym were 0.415 cm3 (range: 0.076 cm3–1.369 cm3) and 6.12% (range:
0.52–25.74%), respectively. DCA plans had a lower average CI value than CCA plans for all groups. CCA plans had a
smaller average V12Gy value than DCA plans for lesions with PTV Asym ≤6.12%, while CCA and DCA plans had
similar average V12Gy values for lesions with PTV Asym > 6.12%.
Conclusions: The DCA technique is recommended when a lesion has PTV Asym > 6.12% regardless of PTV size. For
lesions with PTV Asym ≤6.12%, a technique choice would depend on the preference of CI or V12Gy.
Keywords: Circular collimator arcs, Dynamic conformal arcs, Linac-based stereotactic radiosurgery, Asymmetry,
Conformity index, V12Gy
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Background
One of the treatment modalities for brain metastases is
stereotactic radiosurgery (SRS) [1, 2]. SRS is generally
intended for treating small lesions and size of lesions is
usually limited to ≤4 cm [3–5]. A wide array of treat-
ment techniques for intracranial SRS are available and
such techniques include the Gamma Knife™ (Elekta AB,
Stockholm, Sweden), medical linear accelerator (linac)-
based systems, charged particle (proton or other heavy
ions) therapy, helical TomoTherapy (Accuray Inc.,
Sunnyvale, CA) and the robot-assisted linac system,
Cyber Knife™ (Accuray Inc., Sunnyvale, CA) [5, 6]. Of
these, linac-based systems are capable of multiple delivery
techniques such as circular collimator arcs (CCA), dynamic
conformal arcs (DCA), intensity modulated radiation ther-
apy and volumetric modulated arc therapy (VMAT) [5].
While CCA uses circular cones, the rest of the techniques
require micro multileaf collimators (mMLCs). Treatment
of multiple lesions with a single isocenter approach has
been employed since VMAT was introduced and its deliv-
ery has become highly efficient [7, 8].
Despite the advent of VMAT and its efficiency, CCA
and DCA are still commonly used for the treatment of a
single lesion. Both techniques are relatively simple and
easy to be planned and delivered for a single lesion with
one isocenter. The CCA technique uses multiple nonco-
planar converging arcs with tertiary circular cones and is
a conventional method for linac-based SRS [5, 9]. This
technique is ideally suited for a small spherically-shaped
tumor [3, 10]. Treatment of an irregularly-shaped tumor
is possible using CCA but it often requires multiple
isocenters for a good conformity at the expense of treat-
ment time and dose homogeneity [9–13]. On the other
hand, the DCA technique uses multiple noncoplanar
arcs about a single isocenter with continuously changing
field shape using mMLCs [12, 14]. It is usually used for
a large and/or irregularly-shaped tumor [3, 9, 10].
SRS plan quality is evaluated with various dosimetric
parameters and two common parameters are conformity
index (CI) and volumes of normal brain tissue receiving
at least 8–12 Gy (e.g., V12Gy). CI is presented as a ratio
of the total volume enclosed by the prescription iso-
dose to the target volume [5, 15]. CI indicates a de-
gree of conforming the prescription isodose to shape
of the target and for SRS treatment, CI values below
2.0 are recommended by the Radiation Therapy On-
cology Group [13]. V12Gy is defined as the volume
of normal brain tissue (total brain volume minus
planning target volume (PTV)) receiving 12 Gy or
higher [1, 16] and is known as the most significant
prognostic factor for brain radionecrosis (RN) in SRS
patients [1, 17, 18]. It has been reported that the risk
of symptomatic RN rapidly increases when V12Gy is
greater than 5–10 cm3 [17–19].
Although it is known that CCA is usually suited for
a small spherically-shaped tumor and DCA is for a
large and/or irregularly-shaped tumor [3, 10], a com-
parison of these two techniques in terms of tumor
shape has not been rigorously discussed in the litera-
ture. In this study, herein, CCA and DCA techniques
were compared from a perspective of lesion asym-
metry using the two dosimetric parameters, CI and
V12Gy, for SRS of a small (volumes < 1.4 cm3) single
lesion with a single isocenter approach.
Methods
Patient cohort
A total of 95 patients who received intracranial SRS treat-
ment for a small (volume < 1.4 cm3) single lesion were se-
lected for the current retrospective study. Treatments for
all the selected patients were planned and delivered using
CCA. For the same patient cohort, re-planning was per-
formed using DCA. This study was approved by our insti-
tutional review board.
Clinical circular collimator arc treatment planning
For each patient, CCA treatment planning was per-
formed in the iPlan RT (ver. 4.5.5, Brainlab AG,
Munich, Germany) treatment planning system (TPS)
which supports a pencil beam algorithm with tissue
inhomogeneity corrections. Before treatment planning,
PTV was constructed by a 1-mm expansion from
gross tumor volume delineated with assistance of
magnetic resonance images. Five to six noncoplanar
partial (90–160 degrees) arcs with circular cones (from
7.5 mm to 17.5 mm in diameters in 2.5 mm incre-
ments) were configured with a single isocenter. Vari-
ous beam parameters such as gantry angles, couch
angles, arc length, cone size and beam weighting for
each arc were adjusted such that the plan met our in-
stitutional SRS planning criteria. The planning criteria
include PTV coverage (COV) ≥98.3%, CI ≤1.5 if pos-
sible, V12Gy ≤3.3 cm3 and prescribed isodose line
(IDL) between 50 and 80%. For 95 plans, a prescribed
dose ranged from 16 Gy to 24 Gy with a median value
of 21 Gy. Sixteen plans with a prescribed dose other
than 21 Gy were retrospectively re-scaled to 21 Gy.
Dose grid size was 1 mm × 1 mm × 1.5 mm.
Dynamic conformal arc treatment planning
Ninety-five DCA plans were generated from the 95 clin-
ical CCA plans in the same TPS. Circular cones in each
CCA plan were replaced with mMLCs to create a DCA
plan. Based on our institutional practice, an MLC aperture
margin was set to 0mm to achieve similar prescribed IDL
to that for CCA plans. Isocenter position, gantry and
couch angles, arc length for each arc and beam weighting
were kept the same as for the CCA plan. Each DCA plan
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was adjusted by changing prescribed IDL such that PTV
COV was within ±1.0% from that for the corresponding
CCA plan.
Asymmetry calculation for each PTV
Asymmetry (Asym) was defined and calculated for each
PTV. Following response evaluation criteria in solid tu-
mors 1.1 [20], the longest diameter of PTV and its per-
pendicular diameter on the transverse plane were
measured. Then the longest dimension perpendicular to
the transverse plane was measured. From the mea-
surements, PTV Asym was computed using the fol-
lowing equation:
Asym %ð Þ ¼ a−mj j þ b−mj j þ c−mj j
4m
 100 ð1Þ
where a, b and c are three dimensions of PTV and m is
a mean value of a, b and c. The value “4” in the de-
nominator is a normalization factor to scale Asym
(%) ranging from 0% (most symmetric) to 100% (most
asymmetric).
Grouping and statistical analysis
To compare CCA and DCA plans, statistical analyses
were performed for three different cases. First, without
grouping, 95 clinical CCA plans were compared with re-
planned DCA plans using four dosimetric parameters
(COV, IDL, CI and V12Gy) (one-group analysis). Sec-
ond, a pair of the 95 plans was categorized into two
groups with respect to either PTV size or PTV Asym
and then CCA and DCA plans in each group were com-
pared using two dosimetric parameters (CI and V12Gy)
(two-group analysis). Third, a pair of the 95 plans was
categorized into four groups with respect to both PTV size
and PTV Asym, and then CCA and DCA plans in each
group were compared using CI and V12Gy (four-group
analysis). For each group analysis, a non-parametric test
(i.e., Wilcoxon matched pairs test) was run. A difference in
a dosimetric parameter between CCA and DCA plans
was considered statistically significant when the p-value
was < 0.05. It is noted that CI and V12Gy were used to
compare CCA and DCA plans (one-group, two-group
and four-group analyses) while COV and IDL were used
to generate DCA plans with similar plan quality to
CCA plans.
Results
Two independent variables for grouping: PTV size and
PTV Asym
Statistics of PTV size and PTV Asym for 95 lesions is
as follows. Mean ± standard deviation of PTV size is
0.505 cm3 ± 0.333 cm3 and its range (minimum - max-
imum) is 0.076 cm3–1.369 cm3 with a median value of
0.415 cm3. Those for PTV Asym are 6.64% ± 4.10 and
0.52% - 25.74% with a median value of 6.12%. As shown
in Fig. 1a and b, PTV size and PTV Asym did not follow
normal distributions and were skewed to low values. PTV
Asym as a function of PTV size is displayed in Fig. 1c.
There was no distinct trend (R2 = 0.011 from linear re-
gression line) observed between PTV size and PTV
Asym. The median values of PTV size and PTV Asym
(dotted lines in Fig. 1c) were used to categorize a pair
of the 95 plans for two-group analysis and four-group
analysis.
One-group analysis
Statistics of COV and IDL for 95 CCA and DCA plans is
summarized in Table 1. COV for CCA was slightly
higher than that for DCA (mean: 98.9% vs. 98.8%) and
the COV difference between the two techniques was
statistically significant (p-value = 0.0023). Mean of IDL
(78.9%) for CCA was also higher than that (78.2%) for
DCA and the difference in IDL was statistically signifi-
cant (p-value = 0.0144).
CI comparison between CCA and DCA is shown in
Table 1 and Fig. 2. More conformal plan was feasible
with DCA than with CCA (mean: 1.30 vs. 1.46),
resulting in a statistically significant difference (p-
value < 0.0001) between the two techniques (Table 1).
CI distributions as a function of PTV size showed that
there was no noticeable trend (R2 = 0.2778 for DCA
and R2 = 0.0256 for CCA from linear regression lines)
observed between CI and PTV size (Fig. 2a). Similarly,
CI distributions as a function of PTV Asym revealed
that there was no dependence of CI on PTV Asym
(R2 = 0.0334 for DCA and R2 = 0.3436 for CCA from
linear regression lines) (Fig. 2b). As shown in Fig. 2,
for most lesions, CI values were < 1.5 with DCA, satis-
fying our institutional SRS planning criteria better
than with CCA. The upper 95% confidence interval
(i.e., 97.5 percentile value) of CI for DCA was 1.49 in
comparison with that (1.97) for CCA. In CCA plans,
there were three lesions with CI values > 2.0. Those le-
sions had fairly small PTV sizes (0.144 cm3 - 0.244
cm3) and high PTV Asym values (12.1–25.7%).
V12Gy comparison between CCA and DCA is pre-
sented in Table 1 and Fig. 3. Average V12Gy (1.37 cm3)
for CCA was smaller than that (1.43 cm3) for DCA and
the difference was statistically significant (p-value <
0.0001). V12Gy had a linear relationship with PTV size
for each of CCA and DCA plans (Fig. 3a). Linear regres-
sion lines are V12Gy = 2.0713 × PTV + 0.3226 for CCA
plans and V12Gy = 2.0792 × PTV + 0.3846 for DCA
plans, where V12Gy is the volume receiving 12 Gy or
higher in cm3 for the prescribed dose of 21 Gy and PTV
is the target volume in cm3. DCA plans had a better fit
to the linear regression line than CCA plans (R2: 0.9487
Lee and Kim Radiation Oncology           (2019) 14:91 Page 3 of 10
vs. 0.9115). Figure 3b shows V12Gy distributions as a
function of PTV Asym for 95 lesions. PTV Asym did not
affect V12Gy distributions (R2 = 0.0088 for DCA and
R2 = 0.0013 for CCA from linear regression lines). As
shown in Fig. 3, for most lesions, CCA plans had smaller
V12Gy values than DCA plans.
Two-group analysis
Analysis with respect to PTV size
Table 2 shows two-group analysis with respect to PTV
size. A pair of the 95 plans was divided into two
groups (Group A: PTV size ≤0.415 cm3; Group B:
PTV size > 0.415 cm3) using the median value (0.415
Fig. 1 Distributions of (a) planning target volume (PTV) size and (b) PTV asymmetry (Asym), and (c) the plot of PTV Asym as a function of PTV
size for 95 lesions. Dotted lines represent median values of PTV size (0.415 cm3) and PTV Asym (6.12%)
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cm3) of PTV size. Sample sizes were 48 (50.5%) and
47 (49.5%) for Groups A and B, respectively.
For Group A, DCA plans had a lower average CI
value than CCA plans (1.34 vs. 1.49). The CI difference
between the two techniques was statistically significant
(p-value < 0.0001). For Group B, similar results were
observed. The average CI value (1.26) for DCA plans
was lower than that (1.43) for CCA plans and the dif-
ference was statistically significant (p-value < 0.0001).
Therefore, CI is lower in DCA plans than in CCA plans
regardless of PTV size.
For Group A, CCA plans had a smaller average V12Gy
value than DCA plans (0.82 cm3 vs. 0.87 cm3). There
was a statistically significant difference in V12Gy be-
tween the two techniques (p-value = 0.0017). For Group
B, average V12Gy (1.93 cm3) for CCA plans was also
smaller than that (2.01 cm3) for DCA plans and the
difference was statistically significant (p-value = 0.0051).
Therefore, V12Gy for CCA plans is smaller than for
DCA plans regardless of PTV size.
Analysis with respect to PTV Asym
Table 3 summarizes two-group analysis with respect
to PTV Asym. A pair of the 95 plans was divided
into two groups (Group C: PTV Asym ≤6.12%; Group
Table 1 Comparison between circular collimator arc (CCA) and
dynamic conformal arc (DCA) treatment planning for 95 lesions.
Planning target volume (PTV) coverage (COV) (%), prescribed
isodose line (IDL) (%), conformity index (CI), and V12Gy (cm3)
were compared between CCA and DCA
Parameters COV (%) IDL (%) CI V12Gy (cm3)
Planning technique CCA DCA CCA DCA CCA DCA CCA DCA
Minimum 98.3 98.5 73.6 73.7 1.17 1.15 0.31 0.32
Maximum 99.5 99.5 83.1 81.2 2.42 1.56 3.42 3.44
Mean 98.9 98.8 78.9 78.2 1.46 1.30 1.37 1.43
Median 99.0 98.8 79.4 78.4 1.41 1.28 1.29 1.34
Standard deviation 0.28 0.23 2.00 1.40 0.18 0.09 0.72 0.71
p-value 0.0023 0.0144 < 0.0001 < 0.0001
Fig. 2 Conformity index (CI) as a function of (a) planning target volume (PTV) size and (b) PTV asymmetry (Asym) for 95 lesions. Dotted lines in
(a) and (b) represent median values of PTV size (0.415 cm3) and PTV Asym (6.12%), respectively
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D: PTV Asym > 6.12%) using the median value
(6.12%) of PTV Asym. Sample sizes were 48 (50.5%)
and 47 (49.5%) for Groups C and D, respectively.
For Group C, DCA plans had a lower average CI
value than CCA plans (1.30 vs. 1.41). The CI differ-
ence was statistically significant (p-value < 0.0001).
For Group D, the average CI value (1.30) for DCA
plans was also lower than that (1.52) for CCA plans
and the difference was statistically significant (p-value
< 0.0001). Therefore, CI is lower in DCA plans than
in CCA plans regardless of PTV Asym.
For Group C, CCA plans had a smaller average
V12Gy value than DCA plans (1.36 cm3 vs. 1.48 cm3)
. The V12Gy difference was statistically significant
(p-value < 0.0001). For Group D, average V12Gy
(1.38 cm3) for CCA plans was almost the same as
that (1.39 cm3) for DCA plans and the difference was
not statistically significant (p-value = 0.4002). Therefore,
V12Gy is smaller in CCA plans than in DCA plans for le-
sions with PTV Asym ≤6.12%, while there is no difference
in V12Gy between the two techniques when PTV Asym is
> 6.12%.
Four-group analysis
CI and V12Gy comparisons among four groups
(Groups #1-#4) divided using median values of PTV
size (0.415 cm3) and PTV Asym (6.12%) are presented
in Table 4. Sample sizes of the four groups are 23
(24.2%), 25 (26.3%), 25 (26.3%) and 22 (23.2%) for
Groups #1-#4 in order.
DCA plans had lower average CI than CCA plans for
all four groups. Two groups with PTV size > 0.415 cm3
(Groups #2 and #4) had the lowest average CI value
(1.26) when DCA was used. Group #3 (PTV size
≤0.415 cm3 and PTV Asym > 6.12%) had the highest
(1.54) when CCA was used.
For two groups with PTV Asym ≤6.12% (Group #1
and #2), CCA plans had a smaller average V12Gy value
than DCA plans. On the other hand, for two groups
with PTV Asym > 6.12% (Groups #3 and #4), the two
techniques had similar V12Gy values (p-value > 0.05).
In Group #3 (PTV size ≤0.415 cm3 and PTV Asym >
6.12%), V12Gy for CCA was slightly smaller than for
DCA (0.87 cm3 vs. 0.90 cm3), whereas in Group #4
(PTV size > 0.415 cm3 and PTV Asym > 6.12%),
Fig. 3 V12Gy as a function of (a) planning target volume (PTV) size and (b) PTV asymmetry (Asym) for 95 lesions. Dotted lines in (a) and (b)
represent median values of PTV size (0.415 cm3) and PTV Asym (6.12%), respectively
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V12Gy for CCA was slightly larger than for DCA
(1.97 cm3 vs. 1.95 cm3). Group #1 (PTV size ≤0.415
cm3 and PTV Asym ≤6.12%) had the smallest aver-
age V12Gy value (0.77 cm3) with CCA. Group #2 (PTV
size ≤0.415 cm3 and PTV Asym > 6.12%) had the largest
(2.07 cm3) with DCA.
Discussion
This study limited PTV size to < 1.4 cm3 in comparing
CCA and DCA plans for SRS treatment. Minniti et al.’s
outcome study for 310 brain metastases reported that
the actuarial risk at 1 year for the development of brain
RN was 0% in the first quartile (V12Gy < 3.3 cm3) [18].
To be conservative, our institution follows this V12Gy
constraint. Our experience has shown that lesions with
PTV size > 1.4 cm3 usually do not meet this V12Gy con-
straint in CCA plans. Hence, all subjects included in this
study had PTV size < 1.4 cm3.
As shown in the Results, PTV size and PTV Asym do
not affect CI in CCA and DCA plans (Fig. 2) and CI is
always lower with DCA (Tables 2, 3 and 4). This would
be attributed to field shaping capability of mMLCs in
DCA plans. Several studies also reported that mMLCs
conform to large and/or irregularly-shaped tumors bet-
ter than circular cones [3, 9, 10].
In this study, linear relationships between V12Gy and
PTV size for CCA and DCA techniques were established
(Fig. 3a). Bohoudi et al. derived a linear prediction model
of V12Gy for a given prescribed dose from 30 single
brain metastases with PTV size ranging from 0.14 cm3 to
43.4 cm3 treated using DCA: V12Gy = (0.12 × prescribed
dose – 1.44) × PTV + (0.12 × prescribed dose – 0.96) [1].
This prediction model for a prescribed dose of 21 Gy leads
to V12Gy = 1.08 × PTV + 1.56 (Fig. 4). The comparison of
this model with our linear model (V12Gy = 2.08 × PTV +
0.38 for DCA) shows that Bohoudi et al.’s V12Gy values
are larger than ours for PTV size < 1.2 cm3 (Fig. 4). This
comparison is supported by Bohoudi et al.’s finding: their
model slightly overestimates V12Gy for small tumors [1].
Zhao et al. also derived a linear prediction model of
V12Gy (V12Gy = 1.90 × PTV + 2.11) from 22 clinical tar-
gets with volumes from 0.5 cm3 to 41.7 cm3 treated using
DCA [14]. The slope (1.90) of their model is close to ours
(2.08) (Fig. 4). However, their model was generated for an
MLC aperture margin of 1 mm, whereas ours was ob-
tained without a margin. As a result, their V12Gy values
are larger than ours by a range of 1.4 cm3 to 1.7 cm3.
Except for these models, there has been no published data
on a V12Gy prediction model especially for small tumors.
Therefore, the linear relationships between V12Gy and
PTV size for CCA and DCA techniques obtained in this
study would allow for estimation of V12Gy for PTV
size < 1.4 cm3 and for the prescribed dose of 21 Gy.
The V12Gy comparisons between CCA and DCA shown
in Tables 2, 3 and 4 demonstrated that V12Gy is smaller
with CCA regardless of PTV size. However, V12Gy is
smaller with CCA for lesions with PTV Asym ≤ 6.12%,
while there is no difference in V12Gy between CCA and
DCA techniques for lesions with PTV Asym > 6.12%. Ter-
tiary cones used for the CCA technique increase a source
to diaphragm distance in a linac, resulting in a decrease of
Table 3 Two-group analysis in terms of planning target volume
(PTV) asymmetry (Asym). For each group, CI and V12Gy were
compared between circular collimator arc (CCA) and dynamic
conformal arc (DCA) treatment planning
Group C D
Asyma (%) ≤6.12 > 6.12
Sample size (%) 48 (50.5%) 47 (49.5%)
CI comparison CCA DCA CCA DCA
Minimum 1.21 1.16 1.17 1.15
Maximum 1.75 1.52 2.42 1.56
Mean 1.41 1.30 1.52 1.30
Standard deviation 0.11 0.09 0.22 0.09
p-value < 0.0001 < 0.0001
V12Gy (cm3) comparison CCA DCA CCA DCA
Minimum 0.31 0.32 0.36 0.38
Maximum 3.42 3.44 3.31 2.90
Mean 1.36 1.48 1.38 1.39
Standard deviation 0.74 0.77 0.71 0.64
p-value < 0.0001 0.4002
aThe definition of Asym (%) is in Eq. (1)
Table 2 Two-group analysis in terms of planning target volume
(PTV) size. For each group, CI and V12Gy were compared
between circular collimator arc (CCA) and dynamic conformal
arc (DCA) treatment planning
Group A B
PTV (cm3) ≤0.415 > 0.415
Sample size (%) 48 (50.5%) 47 (49.5%)
CI comparison CCA DCA CCA DCA
Minimum 1.26 1.17 1.17 1.15
Maximum 2.42 1.56 1.81 1.45
Mean 1.49 1.34 1.43 1.26
Standard deviation 0.22 0.09 0.14 0.07
p-value < 0.0001 < 0.0001
V12Gy (cm3) comparison CCA DCA CCA DCA
Minimum 0.31 0.32 1.21 1.36
Maximum 1.45 1.34 3.42 3.44
Mean 0.82 0.87 1.93 2.01
Standard deviation 0.28 0.27 0.60 0.54
p-value 0.0017 0.0051
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geometric penumbra [21]. Sharper penumbra can reduce a
V12Gy value in CCA plans. However, when PTVAsym be-
comes larger (> 6.12%), in CCA plans, both CI and V12Gy
values are increased due to less flexibility of field shaping
with cones. In contrast, in DCA plans, field shaping cap-
ability of mMLCs compensates for an increase of V12Gy.
As a result, V12Gy becomes similar in the two techniques
(1.38 cm3 for CCA vs. 1.39 cm3 for DCA) (Table 3). There-
fore, lesions with PTV Asym > 6.12% can benefit from the
DCA technique in maintaining similar V12Gy.
A dose gradient index (GI) is another tool to measure
dose fall off outside the target and can be a useful pre-
dictor of adverse outcomes in the same way as V12Gy
[22, 23]. The GI, originating from the Gamma Knife
treatment of benign lesions, is defined as the ratio of the
volume of half the prescription isodose to the volume of
the prescription isodose [22, 23]. In our study, V12Gy
was preferred to the GI for plan comparison based on
our institutional practice. For 95 patients (one-group
analysis), GI (mean ± standard deviation: 3.22 ± 0.40;
range: 2.51–4.23) for CCA plans is lower than that
(3.82 ± 0.47; 3.03–5.00) for DCA plans and the difference
is statistically significant (p-value < 0.0001) from the
Wilcoxon matched pairs test. For two-group (A vs. B or
C vs. D) and four-group (1, 2, 3 vs. 4) analyses, the
results are similar: GI for CCA plans is lower and the
differences are statistically significant (p-value < 0.05).
Several studies [23–25] in the literature showed that
the MLC margin between − 1.5 mm and − 0.5 mm yields
the minimum GI. A margin < 0 mm would reduce
V12Gy (and GI) but prescribed IDL will become lower
to achieve the PTV coverage goal. Our institutional
practice shows that most clinical CCA plans had pre-
scribed IDL between 75 and 80% even though our plan-
ning criteria allow for prescribed IDL between 50 and
80%. Likewise, most clinical DCA plans had prescribed
IDL between 75 and 80% and a MLC aperture margin of
0 mm was used. Therefore, based on our institutional
practice, in the current study, 0 mm margin was selected
to generate DCA plans which have similar PTV coverage
and prescribed IDL to those for CCA plans.
Group analyses presented in this study would be useful
in choosing an SRS planning technique between CCA
and DCA for a small single lesion (Tables 2, 3 and 4).
From the information on PTV size and PTV Asym, a
better technique can be selected in terms of CI and
V12Gy. For lesions with PTV Asym > 6.12% (Groups #3
and #4), the DCA technique would be better to achieve
Fig. 4 Comparison of three V12Gy prediction models for the
dynamic conformal arc (DCA) technique
Table 4 Four-group analysis in terms of planning target volume (PTV) size and PTV asymmetry (Asym). For each group, CI and
V12Gy were compared between circular collimator arc (CCA) and dynamic conformal arc (DCA) treatment planning
Group # 1 2 3 4
PTV (cm3) ≤0.415 > 0.415 ≤0.415 > 0.415
Asyma (%) ≤6.12 ≤6.12 > 6.12 > 6.12
Sample size (%) 23 (24.2%) 25 (26.3%) 25 (26.3%) 22 (23.2%)
CI comparison CCA DCA CCA DCA CCA DCA CCA DCA
Minimum 1.26 1.22 1.21 1.16 1.30 1.17 1.17 1.15
Maximum 1.75 1.52 1.69 1.45 2.42 1.56 1.81 1.41
Mean 1.44 1.35 1.38 1.26 1.54 1.33 1.49 1.26
Standard deviation 0.11 0.08 0.11 0.07 0.27 0.10 0.15 0.06
p-value 0.0001 < 0.0001 < 0.0001 < 0.0001
V12Gy (cm3) comparison CCA DCA CCA DCA CCA DCA CCA DCA
Minimum 0.31 0.32 1.21 1.41 0.36 0.38 1.21 1.36
Maximum 1.43 1.24 3.42 3.44 1.45 1.34 3.31 2.90
Mean 0.77 0.84 1.89 2.07 0.87 0.90 1.97 1.95
Standard deviation 0.27 0.27 0.61 0.60 0.28 0.26 0.59 0.47
p-value 0.0013 < 0.0001 0.1266 0.8486
aThe definition of Asym (%) is in Eq. (1)
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lower CI without compromising V12Gy as discussed
above. For those lesions, using DCA, CI values can be
improved by 0.21 for Group #3 (PTV Asym > 6.12% and
PTV size ≤0.415 cm3) and by 0.23 for Group #4 (PTV
Asym > 6.12% and PTV size > 0.415 cm3). For lesions
with PTV Asym ≤6.12% (Groups #1 and #2), the
choice of a technique would depend on the dosimet-
ric parameter (CI or V12Gy) to which the clinician
pays more attention. If lower CI is preferred, DCA
would be a better option with compromised V12Gy.
If smaller V12Gy is preferred, CCA should be used
but CI would be increased.
Conclusions
DCA plans have lower CI than CCA plans regardless
of PTV size or PTV Asym. On the other hand, CCA
plans have smaller average V12Gy for lesions with
PTV Asym ≤6.12% but the two techniques have simi-
lar V12Gy when PTV Asym is larger than 6.12%.
Therefore, for lesions with PTV Asym > 6.12%, re-
gardless of PTV size, the DCA technique would be
more beneficial to achieve lower CI and simultan-
eously, to maintain similar V12Gy compared with the
CCA technique.
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